Monitorización del riesgo cardiovascular y metabólico en niños y adolescentes en tratamiento antipsicótico: un estudio descriptivo transversal

Torre Villalobos, Miguel de la; Martin-López, Luis Miguel; Fernández Sanmartín, María ISabel; Pujals Altes, Elena; Gasque Llopis, Silvia; Batlle Vila, Santiago; Pérez-Solá, Víctor; Novo Navarro, Patricia; Gómez Simón, Isabel; Fresno González, Cristina; Camprodon Rosanas, Ester; Bulbena Vilarrasa, Antonio.
Rev. psiquiatr. salud ment. (Barc., Ed. impr.) ; 11(1): 19-26, ene.-mar. 2018. tab
Artículo en Español | IBECS (España) | ID: ibc-170568

Documentos relacionados

  1. Antipsychotic use among persons with schizophrenia in Sweden and Finland, trends and differences.
  2. Clozapine and mortality: A comparison with other antipsychotics in a nationwide Danish cohort study.
  3. Serious Adverse Drug Reactions to Antipsychotics in Minors with Multiple Disabilities: Preventability and Potential Cost Savings by Therapeutic Drug Monitoring.
  4. Antipsychotic prescribing practices for outpatients with schizophrenia and reasons for non-clozapine treatment - Data from a Danish quality assessment audit.
  5. Greater Arterial Stiffness in Children with or without Second-generation Antipsychotic Treatment for Mental Health Disorders: Rigidité Artérielle Plus Importante Chez Les Enfants Avec ou Sans Traitement Par Antipsychotiques de la Deuxième Génération Pour des Troubles de Santé Mentale.
  6. The Clinical and Economic Burden of Tardive Dyskinesia in Israel: Real-World Data Analysis.
  7. Antipsychotics and obsessive-compulsive disorder/obsessive-compulsive symptoms: A pharmacovigilance study of the FDA adverse event reporting system.
  8. Addressing Metabolic Comorbidity in Individuals With Intellectual and Developmental Disability on Antipsychotics: A Clinical Case Series.
  9. Occurrence of metabolic diseases associated with antipsychotic use among Korean patients with schizophrenia.
  10. Analysis of Antipsychotic Dosage in Patients With Tardive Dyskinesia: A Case-Control Study Using the Claims Database of the Corporate Health Insurance Association.